JIANG Zhi-min, XIE De-rong, LAI Xiao-rong. Real-World Comparative Effectiveness of Nab-Paclitaxel Plus Gemcitabine Versus FOLFIRINOX in Advanced Pancreatic Cancer[J]. Journal of Evidence-Based Medicine, 2019, 19(5): 264-266. DOI: 10.12019/j.issn.1671-5144.2019.05.003
|
Citation:
|
JIANG Zhi-min, XIE De-rong, LAI Xiao-rong. Real-World Comparative Effectiveness of Nab-Paclitaxel Plus Gemcitabine Versus FOLFIRINOX in Advanced Pancreatic Cancer[J]. Journal of Evidence-Based Medicine, 2019, 19(5): 264-266. DOI: 10.12019/j.issn.1671-5144.2019.05.003
|
JIANG Zhi-min, XIE De-rong, LAI Xiao-rong. Real-World Comparative Effectiveness of Nab-Paclitaxel Plus Gemcitabine Versus FOLFIRINOX in Advanced Pancreatic Cancer[J]. Journal of Evidence-Based Medicine, 2019, 19(5): 264-266. DOI: 10.12019/j.issn.1671-5144.2019.05.003
|
Citation:
|
JIANG Zhi-min, XIE De-rong, LAI Xiao-rong. Real-World Comparative Effectiveness of Nab-Paclitaxel Plus Gemcitabine Versus FOLFIRINOX in Advanced Pancreatic Cancer[J]. Journal of Evidence-Based Medicine, 2019, 19(5): 264-266. DOI: 10.12019/j.issn.1671-5144.2019.05.003
|
DownLoad: